Defining The Role Of Kidney CD103+ Dendritic Cells In Kidney Disease For Potential Therapies
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
Chronic Kidney Disease (CKD) is a major cause morbidity. Dendritic cells (DCs) play a central role in the development and progression of CKD. This research is based on our recent novel finding in which CD103+ DCs have been defined, for the first time, as a major subset of kidney DCs, and shown to be pathogenic in many kidney diseases. This research will further investigate the role of CD103+ DCs in various types of CKD and aim to develop therapeutic strategies to target CD103+ DCs to treat CKD.
Where It All Begins- Exploring Dendritic Cell Control Of Viral Infection And Cell Development In The Bone Marrow Of Mice And Man.
Funder
National Health and Medical Research Council
Funding Amount
$96,335.00
Summary
The bone marrow (bm) is the birthplace of all blood cells that fight infection in the body. Dendritic cells (DC), essential for starting immune responses, are found in the bm but the exact types and their functions are unknown. I plan to investigate the DC types that reside in the bm and explore their role in inducing immune responses and in influencing the development of cells from the bm with potential attributable benefits for stem cell transplant and vaccine design.
The Role Of Signal Transducer And Activator Of Transcription- (STAT) Related Proteins In Dendritic Cells During Chronic Active Infections
Funder
National Health and Medical Research Council
Funding Amount
$95,313.00
Summary
Chronic infections produced by pathogens such as HIV, overwhelm our immune system leading to an exhausted state where cells responsible for the clearance of invading microorganisms are unable to respond effectively. We have recently identified a highly promising therapeutic target that enhances immune effector function. We seek to understand the underlying mechanism, and to explore its therapeutic potential for use as a common platform to treat diverse infections.
Defining The Cellular Basis For Therapeutic Angiogenesis: Characterisation Of Endothelial Progenitor Cell Populations
Funder
National Health and Medical Research Council
Funding Amount
$100,943.00
Summary
Cardiovascular disease is the leading cause of death in the Australia. Endothelial progenitor cells (EPCs), similar to stem cells, have strong self-renewal capabilities and the ability to mature further. There has been immense interest in using EPCs as they are believed to have a role in the growth and repair of blood vessels. This research systematically studies two candidate EPCs, the early EPC and the outgrowth EPC (OEC), and potentially paves the way for using EPCs to treat heart disease.
Dynamic Imaging Of The Immune Response In Lymph Nodes By Two-photon Microscopy
Funder
National Health and Medical Research Council
Funding Amount
$79,514.00
Summary
Despite the enormous contribution of vaccination to the prevention of human disease and suffering, little is known about the laws that govern the selection and survival of B cells during the response to infection or vaccination. Our research projects aim to integrate several cutting-edge technologies, including two-photon microscopy, in order to understand the cellular and molecular basis of immunity.
Mechanisms Of T Cell Mediated Injury In Renal Vasculitis
Funder
National Health and Medical Research Council
Funding Amount
$133,351.00
Summary
Anti-MPO glomerulonephritis (GN) is an aggressive disease causing severe and permanent injury to kidneys. This disease is thought to be due to an immune-mediated response to a protein (MPO) in neutrophils (a type of white blood cell). There is some evidence that other immune cells, CD4+ T cells, may be important in this disease. Experiments using models of anti-MPO GN will aim to define the role and mechanisms by which CD4+ T cells cause inflammation in the kidney.
Optimising Human Vascularisation And Liver Tissue Engineering Models To Develop Functional Bio-artificial Human Liver Tissue
Funder
National Health and Medical Research Council
Funding Amount
$124,761.00
Summary
This project aims to grow human blood vessels and liver cells derived from human stem cells within a supporting scaffold to generate a “liver in a dish”. Transplantation involves connecting blood vessels in this structure to those of the recipient. This should restore function in mice with human-like liver disease, thereby demonstrating potential of this technology to be developed as an alternative to liver transplantation.
Correction Of Friedreich Ataxia Induced Pluripotent Stem Cells By Non-viral Gene Therapy
Funder
National Health and Medical Research Council
Funding Amount
$63,270.00
Summary
Friedreich ataxia (FRDA) is an inherited progressive disorder of the nervous system and heart. Stem cell therapy has the potential to repair or replace damaged tissues and restore organ function in FRDA patients. The defect inherent in stem cells obtained from FRDA patients will be corrected by a gene therapy approach that will restore normal FRDA gene expression and addresses major safety concerns for the clinical use of corrected stem cells in transplantation medicine.
Improving 3D Scaffolds For Skin Tissue Engineering Using Advanced Biotechnology
Funder
National Health and Medical Research Council
Funding Amount
$68,971.00
Summary
Burns injuries are among the most physically and psychologically debilitating injuries. Patients who suffer from severe, extensive burn injuries can have a shortage of healthy, undamaged donor sites and so skin substitutes are used as alternatives to provide wound healing. However, the newly produced skin does not appear or function normally. The aim of this project is to develop a skin equivalent which will provide rapid regeneration of normal skin and improve a patient’s quality of life.